Revenue segments as reported by the company.

Beauty

Grooming

Health Care

Fabric & Home Care

Baby, Feminine & Family Care

Corporate

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Goodwill and indefinite-lived intangibles impairment charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Procter & Gamble

Old Spice is a brand of male grooming products encompassing deodorants and antiperspirants, shampoos, body washes, and soaps.

Old Spice

Crest is a brand of toothpaste and other oral hygiene products sold worldwide.

Crest

Tampax is a brand of tampon sold in over 100 countries.

Tampax

Tide

Braun AG, is a German consumer products company based in Kronberg. From 1984 until 2007, Braun was a wholly owned subsidiary of The Gillette Company, which had purchased a controlling interest in the company in 1967. Braun is now a wholly owned subsidiary of Procter & Gamble, which acquired Gillette in 2005. On 16 April 2012, De'Longhi bought perpetual rights to manufacture Braun branded products from Procter & Gamble in the small appliance segment. Procter & Gamble will continue to own the Braun brand.

Braun

Gillette is a brand of men's and women's safety razors and other personal care products including shaving supplies.

Gillette

Olay is a brand of beauty products focusing on skin care.

Olay

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Procter & Gamble reports strong Q3 performance and navigates challenges

Procter & Gamble delivered strong Q3 results, raising its guidance for organic sales growth and maintaining its outlook for core earnings per share growth. The company faces challenges related to sustained cost pressures, supply constraints, and volume recovery in certain regions. However, opportunities exist in travel retail reopening, innovation strategies, and continued resilience.

Procter & Gamble reports Q2 growth amid global challenges

Procter & Gamble's Q2 showed mixed results with strong U.S. sales but challenges in Greater China.
Guidance raised for organic sales growth, but significant headwinds persist from raw material costs and currency fluctuations.
Investments in brand superiority and supply chain optimization present growth opportunities.
Balancing input cost inflation and navigating market uncertainties remain key challenges.

Procter & Gamble reports robust Q3 results amidst global challenges

Procter & Gamble's Q3 performance reflects strong execution of strategies, leading to organic sales growth and margin improvement.
Despite challenges from costs and supply constraints, P&G's focus on innovation and market leadership positions it well for future growth.
Opportunities in China, Latin America, and Europe, along with continued productivity improvements, offer avenues for sustained growth and market expansion.
P&G's long-term approach to navigating challenges and serving stakeholders effectively underscores its resilience and commitment to sustainable growth.

Procter & Gamble posts robust Q4 earnings amidst market challenges

Procter & Gamble (PG) reported strong financial performance in Q4 2023 and fiscal year 2023, driven by organic sales growth and operational efficiency.
The company's strategic focus on innovation, market share growth, and cost management positions it well to navigate challenges and capitalize on opportunities.
Despite challenges in the China market and supply chain disruptions, P&G remains committed to driving growth, enhancing productivity, and delivering shareholder value.

Procter & Gamble reports strong Q1 results and outlines growth strategies

Procter & Gamble's Q1 performance reflects robust sales growth and financial strength.
While facing challenges in certain regions, the company remains focused on driving innovation and value creation.
Opportunities in commodity tailwinds and marketing investments position PG for continued growth.
Confidence in strategy and commitment to balanced growth underscore PG's resilience.

Procter & Gamble reports robust Q2 earnings amidst market challenges

Procter & Gamble's Q2 2024 earnings call showcased strong performance, emphasizing sales growth, margin improvement, and strategic focus on innovation. While facing challenges in key markets, P&G remains resilient and focused on overcoming obstacles to drive growth. The company's opportunities lie in maintaining sales growth, enhancing earnings, and strategic market decisions.

Procter & Gamble (PG) posts robust Q3 results, eyes innovation for growth

Procter & Gamble (PG) reported strong Q3 performance, highlighting growth in key markets and increased earnings. Despite challenges in China and the Middle East, the company remains focused on innovation and market growth to drive future success.

Procter & Gamble reports strong Q4 results, eyes innovation for growth

Procter & Gamble's Q4 performance showcases resilience and strategic focus amidst regional challenges. The company's emphasis on innovation, market growth, and consumer delight positions it well for sustained positive results and value creation.

Procter & Gamble reports 2% organic sales growth in Q1 2025

Procter & Gamble delivered steady organic sales growth, strong core earnings, and maintained guidance for fiscal year '25. Challenges in Greater China and Europe require attention, while opportunities in Latin America and shareholder value creation through dividends and stock repurchases are key focus areas.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clorox

The tortoise is boring, but slow and steady is usually what dividend investors want to see. Despite a rough patch, Procter & Gamble has rewarded investors well over the past decade.

2 Stocks That Turned $10,000 Into $24,000 (or More)

Kroger

Check out these two blue chip stocks this week.

2 Blue Chip Stocks To Watch In March 2023

Abbott Labs

Johnson & Johnson

Growth stocks have clearly led the market thus far in 2023, but will that continue?

3 Value Stocks on Sale Now

AbbVie

Colgate-Palmolive

Coca-Cola

Northwest Natural Gas

Sysco

Though the term dividend aristocrats generate plenty of interest for the underlying elite status, another even more rarefied category exists called dividend kings to buy. Rather than 25 years of consecutive payout growth, the kings command at least 50 years.

7 Dividend Kings to Buy for an Uncertain Market Environment

These companies have superb track records of paying and raising their dividends. J&J is preparing for a major business shift that could drive better growth and returns in the future.

My Favorite Dividend Stocks for 2023

Apple

Celsius Holdings

Salesforce

Chevron

New Oriental Education & Technology Group

Enphase Energy

JPMorgan Chase & Co

Merck

Northern Oil and Gas

Superior Industries International

Walmart

Two new Breakout Stocks for Week 10 with better than 10% short-term upside and a Dow 30 Picks. Average cumulative returns for 2023 are +38.0% YTD. The Momentum Gauges® were negative from Week 8 with a positive signal late in Week 9. ARAV jumped 12% to end the week with strong momentum.

MDA Breakout Stocks Week 10 - March 2023: High-Frequency Gainers To Give You An Edge

The Procter & Gamble Company's recent earnings report showed the company's brands have staying power, so Procter has weathered the storm. The company should see earnings accelerate in the next 3-5 yeas as inflation levels likely moderate and Asia reopens.

Procter & Gamble: A Buy, Undervalued With Near-Term Catalysts

Unilever

Procter & Gamble revamped its business with the help of activist investor Nelson Peltz, who's now on Unilever's board.

Can Unilever Win With Procter & Gamble's Playbook?

Staples stocks generated alpha in 2022, but many now trade at valuations that are just too high. PG is one such name that will likely not see the kind of flight to safety as seen last year.

Procter & Gamble: Substantial Risks With Shares Expensive And Bearish Technical Signs

Caterpillar

CVS Health

Citizens & Northern

Deere & Company

General Dynamics

General Mills

Hormel Foods

Kinder Morgan

Norwood Financial

Realty Income Corp

Orrstown Financial

Provident Financial Services

Starbucks

AT&T

Verizon

WestRock

Investing in dividend stocks allows you to earn dividend income, the best passive income stream. As I stated in my December 2022 post, 2022 finished off down, ending up below 3,900! The market was down 20% for 2022.

Dividend Income Summary: Lanny's February 2023 Summary

J.P. Morgan Securities this morning upgraded Procter & Gamble Co (NYSE:PG) to "overweight" from "neutral," with a price-target hike to $155 from $150, saying the blue-chip giant could be an "earnings compounder.

Procter & Gamble Stock Receives J.P. Morgan Upgrade

Freeport-McMoRan

Mondelez

Exxon Mobil

Eli Salzmann, manager of the Neuberger Berman Large Cap Value Fund (NPRTX), doesn't expect the early-year stock market rally to last. The post This Top Fund Manager Expects A Big Drop In Stocks appeared first on Investor's Business Daily.

This Top Fund Manager Expects A Big Drop In Stocks

There is more to the comparison, and in the sections below, we discuss why we believe PG stock will offer better returns than CL stock in the next three years.

Should You Buy This Households & Personal Products Company Over Colgate-Palmolive Stock?

P&G is laser-focused on one thing and it permeates the company, sustaining the consumer staples giant's success.

Here's What Smart Investors Know About Procter & Gamble Stock

Dollar General

MercadoLibre

These three resilient stocks could outperform the market this year.

Why MercadoLibre, Procter & Gamble, and Dollar General Are No-Brainer Buys Right Now

There is more to the comparison, and in the sections below, we discuss the possible returns for P&G and AbbVie in the next three years.

This Pharmaceuticals Company Looks To Be A Better Pick Over Procter & Gamble Stock

Aravive Inc

Disney

Permian Basin Royalty Trust

Two new Breakout Stocks for Week 9 with better than 10% short-term upside and a Dow 30 Pick. Average cumulative returns for 2023 are +35.8% YTD. This week, the Momentum Gauges® turned negative for the first time in 2023 with an early negative test signal Feb. 3rd warning of deteriorating market conditions.

MDA Breakout Stocks Week 9 - March 2023: High-Frequency Gainers To Give You An Edge

The Procter & Gamble Company (NYSE:PG ) CAGNY 2023 Conference Call February 23, 2023 9:00 AM ET Company Participants Jon Moeller - Chairman, President and CEO Andre Schulten - CFO John Chevalier - VP, IR Conference Call Participants Kevin Grundy - Jefferies Robert Ottenstein - Evercore ISI Unidentified Company Representative P&G would like to remind you that today's discussion will include a number of forward-looking statements. If you will refer to P&G's most recent 10-K, 10-Q and 8-K reports, you will see a discussion of factors that could cause the company's actual results to differ materially from these projections.

The Procter & Gamble Company (PG) Presents at CAGNY 2023 Conference (Transcript)

News for Procter & Gamble Stock (PG)